Macrophage migration inhibitory factor enzymatic activity, lung inflammation, and cystic fibrosis

American Journal of Respiratory and Critical Care Medicine

Volumn 186, Issue 2, 2012, Pages 162-169

  Adamali, Huzaifa ^a   Armstrong, Michelle E ^a   McLaughlin, Anne Marie ^b   Cooke, Gordon ^a   McKone, Edward ^c   Costello, Christine M ^a   Gallagher, Charles G ^c   Leng, Lin ^d   Baugh, John A ^a   Fingerle Rowson, Günter ^e   Bucala, Richard J ^d   McLoughlin, Paul ^a   Donnelly, Seamas C ^a,c  

^a UNIVERSITY COLLEGE DUBLIN   (Ireland)

^b ST JAMES S HOSPITAL   (Ireland)

^c ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

Author keywords

Cytokines; Infection; Inflammation; Macrophage migration inhibitory factor (MIF)

Indexed keywords

CELL ENZYME; ENZYME INHIBITOR; ISO 1; LIPOPOLYSACCHARIDE; MACROPHAGE MIGRATION INHIBITION FACTOR; MESSENGER RNA; TAUTOMERASE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL LOAD; CELL COUNT; CONTROLLED STUDY; CYSTIC FIBROSIS; DRUG ACTIVITY; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE; GENOTYPE; HUMAN; HUMAN CELL; MACROPHAGE MIGRATION INHIBITION FACTOR GENE; MAJOR CLINICAL STUDY; MALE; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PNEUMONIA; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN POLYMORPHISM; PROTEIN SYNTHESIS; PSEUDOMONAS INFECTION; WEIGHT REDUCTION;

ADULT; ALLELES; ANIMALS; CYSTIC FIBROSIS; FEMALE; GENE KNOCK-IN TECHNIQUES; HUMANS; MACROPHAGE MIGRATION-INHIBITORY FACTORS; MALE; MICE; MICE, INBRED C57BL; PNEUMONIA; POLYMORPHISM, GENETIC; PSEUDOMONAS INFECTIONS; REAL-TIME POLYMERASE CHAIN REACTION; REPETITIVE SEQUENCES, NUCLEIC ACID; RESPIRATORY TRACT INFECTIONS; RETROSPECTIVE STUDIES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84863915825     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.201110-1864OC     Document Type: Article

References (35)

1. Roger T, David J, Glauser MP, Calandra T. MIF regulates innate immune responses through modulation of toll-like receptor 4. Nature 2001;414:920-924. (Pubitemid 34024744)
2. Donnelly SC, Haslett C, Reid PT, Grant IS, Wallace WA, Metz CN, Bruce LJ, Bucala R. Regulatory role for macrophage migration inhibitory factor in acute respiratory distress syndrome. Nat Med 1997;3:320-323. (Pubitemid 27112930)
3. Morand EF, Leech M. Macrophage migration inhibitory factor in rheumatoid arthritis. Front Biosci 2005;10:12-22. (Pubitemid 40543012)
4. Rossi AG, Haslett C, Hirani N, Greening AP, Rahman I, Metz CN, Bucala R, Donnelly SC. Human circulating eosinophils secrete macrophage migration inhibitory factor (MIF). Potential role in asthma. J Clin Invest 1998;101:2869-2874. (Pubitemid 28294596)
5. Calandra T, Bernhagen J, Mitchell RA, Bucala R. The macrophage is an important and previously unrecognized source of macrophage migration inhibitory factor. J Exp Med 1994;179:1895-1902. (Pubitemid 24155670)
6. Calandra T, Echtenacher B, Roy DL, Pugin J, Metz CN, Hultner L, Heumann D, Mannel D, Bucala R, Glauser MP. Protection from septic shock by neutralization of macrophage migration inhibitory factor. Nat Med 2000;6:164-170. (Pubitemid 30082360)
7. Calandra T, Bucala R. Macrophage migration inhibitory factor: a counter-regulator of glucocorticoid action and critical mediator of septic shock. J Inflamm 1995;47:39-51. (Pubitemid 26376200)
8. Mitchell RA, Metz CN, Peng T, Bucala R. Sustained mitogen-activated protein kinase (MAPK) and cytoplasmic phospholipase A2 activation by macrophage migration inhibitory factor (MIF). Regulatory role in cell proliferation and glucocorticoid action. J Biol Chem1999;274:18100-18106.
9. Mitchell RA, Liao H, Chesney J, Fingerle-Rowson G, Baugh J, David J, Bucala R. Macrophage migration inhibitory factor (MIF) sustains macrophage proinflammatory function by inhibiting p53: regulatory role in the innate immune response. Proc Natl Acad Sci USA 2002;99:345-350. (Pubitemid 34060365)
10. Hudson JD, Shoaibi MA, Maestro R, Carnero A, Hannon GJ, Beach DH. A proinflammatory cytokine inhibits p53 tumor suppressor activity. J Exp Med 1999;190:1375-1382.
11. Bozza M, Satoskar AR, Lin G, Lu B, Humbles AA, Gerard C, David JR. Targeted disruption of migration inhibitory factor gene reveals its critical role in sepsis. J Exp Med 1999;189:341-346. (Pubitemid 29063255)
12. Lubetsky JB, Swope M, Dealwis C, Blake P, Lolis E. Pro-1 of macrophage migration inhibitory factor functions as a catalytic base in the phenylpyruvate tautomerase activity. Biochemistry 1999;38:7346-7354.
13. Bendrat K, Al-Abed Y, Callaway DJ, Peng T, Calandra T, Metz CN, Bucala R. Biochemical and mutational investigations of the enzymatic activity of macrophage migration inhibitory factor. Biochemistry 1997;36:15356-15362. (Pubitemid 27528002)
14. Rosengren E, Bucala R, Aman P, Jacobsson L, Odh G, Metz CN, Rorsman H. The immunoregulatory mediator macrophage migration inhibitory factor (MIF) catalyzes a tautomerization reaction. Mol Med 1996;2:143-149.
15. Al-Abed Y, Dabideen D, Aljabari B, Valster A, Messmer D, Ochani M, Tanovic M, Ochani K, Bacher M, Nicoletti F, et al. Iso-1 binding to the tautomerase active site of MIF inhibits its proinflammatory activity and increases survival in severe sepsis. J Biol Chem 2005;280:36541-36544. (Pubitemid 41587728)
16. Fingerle-Rowson G, Kaleswarapu DR, Schlander C, Kabgani N, Brocks T, Reinart N, Busch R, Schutz A, Lue H, Du X, et al. A tautomerase-null macrophage migration-inhibitory factor (MIF) gene knock-in mouse model reveals that protein interactions and not enzymatic activity mediate MIF-dependent growth regulation. Mol Cell Biol 2009;29:1922-1932.
17. Dodge JA, Morison S, Lewis PA, Coles EC, Geddes D, Russell G, Littlewood JM, Scott MT. Incidence, population, and survival of cystic fibrosis in the UK, 1968-95. UK cystic fibrosis survey management committee. Arch Dis Child 1997;77:493-496.
18. Cashman SM, Patino A, Delgado MG, Byrne L, Denham B, De Arce M. The Irish cystic fibrosis database. J Med Genet 1995;32:972-975.
19. Baugh JA, Chitnis S, Donnelly SC, Monteiro J, Lin X, Plant BJ, Wolfe F, Gregersen PK, Bucala R. A functional promoter polymorphism in the macrophage migration inhibitory factor (MIF) gene associated with disease severity in rheumatoid arthritis. Genes Immun 2002;3:170-176. (Pubitemid 38961128)
20. Plant BJ, Gallagher CG, Bucala R, Baugh JA, Chappell S, Morgan L, O'Connor CM, Morgan K, Donnelly SC. Cystic fibrosis, disease severity, and a macrophage migration inhibitory factor polymorphism. Am J Respir Crit Care Med 2005;172:1412-1415. (Pubitemid 43069814)
21. Armstrong ME, Gantier M, Li L, Chung WY, McCann A, Baugh JA, Donnelly SC. Small interfering RNAs induce macrophage migration inhibitory factor production and proliferation in breast cancer cells via a double-stranded RNA-dependent protein kinase-dependent mechanism. J Immunol 2008;180:7125-7133.
22. Hopkins N, Cadogan E, Giles S, McLoughlin P. Chronic airway infection leads to angiogenesis in the pulmonary circulation. J Appl Physiol 2001;91:919-928. (Pubitemid 32681128)
23. Wu J, Zhang W, Xie B, Wu M, Tong X, Kalpoe J, Zhang D. Detection and toxin typing of clostridium perfringens in formalin-fixed, paraffin-embedded tissue samples by PCR. J Clin Microbiol 2009;47:807-810.
24. Deschaght P, De Baere T, Van Simaey L, Van Daele S, De Baets F, De Vos D, Pirnay JP, Vaneechoutte M. Comparison of the sensitivity of culture, PCR and quantitative real-time PCR for the detection of pseudomonas aeruginosa in sputum of cystic fibrosis patients. BMC Microbiol 2009;9:244.
25. Nadkarni MA, Martin FE, Jacques NA, Hunter N. Determination of bacterial load by real-time PCR using a broad-range (universal) probe and primers set. Microbiology 2002;148:257-266. (Pubitemid 34083204)
26. Baumann R, Casaulta C, Simon D, Conus S, Yousefi S, Simon HU. Macrophage migration inhibitory factor delays apoptosis in neutrophils by inhibiting the mitochondria-dependent death pathway. FASEB J 2003;17:2221-2230. (Pubitemid 37509578)
27. Henig NR, Tonelli MR, Pier MV, Burns JL, Aitken ML. Sputum induction as a research tool for sampling the airways of subjects with cystic fibrosis. Thorax 2001;56:306-311. (Pubitemid 32269812)
28. Colombo C, Faelli N, Tirelli AS, Fortunato F, Biffi A, Claut L, Cariani L, Dacco V, Prato R, Conese M. Analysis of inflammatory and immune response biomarkers in sputum and exhaled breath condensate by a multi-parametric biochip array in cystic fibrosis. Int J Immunopathol Pharmacol 2011;24:423-432.
29. Bonfield TL, Panuska JR, Konstan MW, Hilliard KA, Hilliard JB, Ghnaim H, Berger M. Inflammatory cytokines in cystic fibrosis lungs. Am J Respir Crit Care Med 1995;152:2111-2118.
30. Kerem E, Reisman J, Corey M, Canny GJ, Levison H. Prediction of mortality in patients with cystic fibrosis. N Engl J Med 1992;326:1187-1191.
31. Corey M, Edwards L, Levison H, Knowles M. Longitudinal analysis of pulmonary function decline in patients with cystic fibrosis. J Pediatr 1997;131:809-814. (Pubitemid 28027602)
32. Silva LC, Ortigosa LC, Benard G. Anti-TNF-alpha agents in the treatment of immune-mediated inflammatory diseases: mechanisms of action and pitfalls. Immunotherapy 2010;2:817-833.
33. Gadjeva M, Nagashima J, Mitchell RA, Pier GB. Inhibition of macrophage migration inhibitory factor ameliorates ocular pseudomonas aeruginosa-induced keratitis. PLoS Pathog 2010;6:e1000826.
34. Pui CH, Evans WE. Treatment of acute lymphoblastic leukemia. N Engl J Med 2006;354:166-178. (Pubitemid 43076714)
35. Mellinghoff IK, Wang MY, Vivanco I, Haas-Kogan DA, Zhu S, Dia EQ, Lu KV, Yoshimoto K, Huang JH, Chute DJ, et al. Molecular determinants of the response of glioblastomas to EGFR kinase inhibitors. N Engl J Med 2005;353:2012-2024. (Pubitemid 41609094)